EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
Operating Margin for EyePoint Pharmaceuticals (EYPT)
Operating Margin as of May 2024 (TTM): -158.14%
According to EyePoint Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -158.14%. At the end of 2021 the company had an Operating Margin of -158.14%.
Operating Margin history for EyePoint Pharmaceuticals from 2002 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -158.14% | 19.97% |
| 2020 | -131.82% | -52.73% |
| 2019 | -278.88% | -84.47% |
| 2018 | -1,795.71% | 632.37% |
| 2017 | -245.19% | -81.7% |
| 2016 | -1,339.63% | -5623.4% |
| 2015 | 24.25% | -106.25% |
| 2014 | -388.28% | -30.76% |
| 2013 | -560.76% | -20.92% |
| 2012 | -709.13% | 298.02% |
| 2011 | -178.17% | -568.01% |
| 2010 | 38.07% | -233.74% |
| 2009 | -28.47% | -98.7% |
| 2008 | -2,190.82% | -61.51% |
| 2007 | -5,691.41% | 198.06% |
| 2006 | -1,909.47% | 4.65% |
| 2005 | -1,824.63% | -7.38% |
| 2004 | -1,969.97% | -59.3% |
| 2003 | -4,839.72% | 1009.85% |
| 2002 | -436.07% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 148,350.74% | Bahamas |
 NRC Health
NRC | 32.86% | -120.78% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.